Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fenaux

Showing results (141-150 of 412) with videos related to

Pageof 42
Sort By:
British Journal of Haematology|February 1, 1990
Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 casesI Quiquandon, P Fenaux, M T Caulier, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Is translocation (8;21) a "favorable" cytogenetic rearrangement in acute myeloid leukemia?P Fenaux, J L Laï, C Preudhomme, et al.
Blut|April 1, 1990
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 casesP Fenaux, I Quiquandon, M T Caulier, et al.
Leukemia & Lymphoma|August 26, 1998
Fas/APO-1 (CD95) expression in myelodysplastic syndromesP Lepelley, N Grardel, O Erny, et al.
British Journal of Haematology|September 1, 1995
Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomyM T Caulier, F Darloy, C Rose, et al.
Gene Therapy|February 7, 2003
Gamma-irradiation enhances transgene expression in leukemic cellsR Vereecque, A Saudemont, T J Wickham, et al.
Blood|November 1, 1990
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical resultsS Castaigne, C Chomienne, M T Daniel, et al.
Leukemia|January 1, 1996
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignanciesE Wattel, M Vanrumbeke, M A Abina, et al.
Presse Medicale (Paris, France : 1983)|January 23, 1988
[Efficacy of pipobroman in the treatment of essential thrombocythemia]F Bauters, J P Jouet, M Simon, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Pageof 42

Showing results (141-150 of 412) with videos related to

Sort By:
Pageof 42
British Journal of Haematology|February 1, 1990
Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 casesI Quiquandon, P Fenaux, M T Caulier, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Is translocation (8;21) a "favorable" cytogenetic rearrangement in acute myeloid leukemia?P Fenaux, J L Laï, C Preudhomme, et al.
Blut|April 1, 1990
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 casesP Fenaux, I Quiquandon, M T Caulier, et al.
Leukemia & Lymphoma|August 26, 1998
Fas/APO-1 (CD95) expression in myelodysplastic syndromesP Lepelley, N Grardel, O Erny, et al.
British Journal of Haematology|September 1, 1995
Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomyM T Caulier, F Darloy, C Rose, et al.
Gene Therapy|February 7, 2003
Gamma-irradiation enhances transgene expression in leukemic cellsR Vereecque, A Saudemont, T J Wickham, et al.
Blood|November 1, 1990
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical resultsS Castaigne, C Chomienne, M T Daniel, et al.
Leukemia|January 1, 1996
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignanciesE Wattel, M Vanrumbeke, M A Abina, et al.
Presse Medicale (Paris, France : 1983)|January 23, 1988
[Efficacy of pipobroman in the treatment of essential thrombocythemia]F Bauters, J P Jouet, M Simon, et al.
La Revue De Medecine Interne|May 6, 2019
[Management of myelodysplastic syndromes in 2019: An update]T Comont, K Delavigne, P Cougoul, et al.
Pageof 42